Skip to main content
. 2022 Nov 24;58(12):1722. doi: 10.3390/medicina58121722

Figure 1.

Figure 1

Favourable effects of therapy with extracorporeal photopheresis (ECP) to treat skin and mucosa advanced chronic graft-versus-host disease (cGVHD): (A) presentation of symptoms before treatment (+304 day post allo-HSCT); (B) partial regression after two ECP procedures (+310 day post allo-HSCT); and (C) almost complete response after four ECP procedures (+326 day post allo-HSCT).